ACTIVE

ABBVIE

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
6,4 M €
-3.0% YoY
Revenue
265,6 M €
+13.9% YoY
Equity
182,7 M €
-1.5% YoY
Workforce
213,4 ETP
+6.3% YoY

What does ABBVIE do?

ABBVIE is a Public limited company incorporated in 2012. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Wavre. It employs on average 213,4 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0845.096.860
Incorporation
05/04/2012
Legal form
Public limited company
Registered office
Avenue Einstein 14
1300 Wavre · WallonieSee on map
Contributed capital
166 088 088,10 €
Latest accounts
31/12/2025
Average workforce
213,4 ETP
Activities (NACE)
46460Wholesale of pharmaceutical goods· main46460Wholesale of pharmaceutical goods
Joint committees (1)
  • 200
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 7 financial years

2025202420232018201720162015
Income statement
Revenue265,6 M €233,2 M €193,3 M €200,6 M €184,2 M €172,3 M €170,7 M €
EBITDA12,5 M €11,4 M €9 M €-73,7 k €-11,3 M €-9,3 M €-1,8 M €
Operating result9 M €7,6 M €6,5 M €-770,5 k €-12,5 M €-10,6 M €-3,1 M €
Net result6,4 M €6,6 M €6,3 M €-2,1 M €43,2 M €56,4 M €-4,5 M €
Balance sheet
Equity182,7 M €185,6 M €194,9 M €77,4 M €79,5 M €78,2 M €73,6 M €
Total assets227,4 M €231,4 M €239,5 M €116,1 M €122,4 M €127,6 M €105,9 M €
Cash––52,9 k €–––2,5 M €
Debts41,4 M €43,8 M €43,9 M €36,8 M €41,6 M €49 M €32,2 M €
Other
Workforce213,4 ETP200,8 ETP191,3 ETP142,6 ETP147,2 ETP148,0 ETP148,5 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 15 ended

Active mandates

Erica Silbiger

Director · since 01 avril 2026 · until 26 mai 2028

Active
Rolfe van de Spreng

Director · since 01 décembre 2025 · until 31 mars 2026

Active
Renaud Decroix

Chairman of the board of directors · since 31 mai 2024 · until 28 mai 2027

Active
Arnaud Jean Jacques Coint-Bavarot

Director · since 01 mai 2022 · until 29 mai 2026

Active
Jean Antoine De Los Frailes

Director · since 08 décembre 2017 · until 30 novembre 2025

Active

Ended mandates

Meike Elisabeth Celine Colette Kerstens

Director · since 01 mai 2022 · until 12 avril 2024

Ended
Renaud Decroix

Chairman of the board of directors · since 01 août 2020 · until 31 mai 2024

Ended
Robert Andrew Michael

Director · since 29 mars 2019 · until 30 mai 2025

Ended
Jean Antoine De Los Frailes

Director · since 08 décembre 2017 · until 26 mai 2023

Ended
At this address

Other companies at this address

CompanyCBE no.
ABBOTT● Active
0403.044.007
SYNDESI THERAPEUTICS● Active
0686.599.355
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date08/06/202617/06/202507/06/202412/06/202309/06/202209/06/2021
General meeting29/05/202630/05/202531/05/202426/05/202330/05/202228/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

14 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202529/05/202608/06/2026FrenchPDF
Full model31/12/202430/05/202517/06/2025FrenchPDF
Full model31/12/202331/05/202407/06/2024FrenchPDF
Full model31/12/202226/05/202312/06/2023FrenchPDF
Full model31/12/202130/05/202209/06/2022FrenchPDF
Full model31/12/202028/05/202109/06/2021FrenchPDF
Full model31/12/201929/05/202030/06/2020FrenchPDF
Full model31/12/201831/05/201922/07/2019FrenchPDF
Full model31/12/201725/05/201820/06/2018FrenchPDF
Full model31/12/201626/05/201722/06/2017FrenchPDF
Full model31/12/201527/05/201601/07/2016FrenchPDF
Full model31/12/201429/05/201524/06/2015FrenchPDF
Full model31/12/201330/05/201419/06/2014FrenchPDF
Full model31/12/201231/05/201301/08/2013FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 15 ended

Active mandates

Erica Silbiger

Director · since 01 avril 2026 · until 26 mai 2028

Active
Rolfe van de Spreng

Director · since 01 décembre 2025 · until 31 mars 2026

Active
Renaud Decroix

Chairman of the board of directors · since 31 mai 2024 · until 28 mai 2027

Active
Arnaud Jean Jacques Coint-Bavarot

Director · since 01 mai 2022 · until 29 mai 2026

Active
Jean Antoine De Los Frailes

Director · since 08 décembre 2017 · until 30 novembre 2025

Active

Ended mandates

Meike Elisabeth Celine Colette Kerstens

Director · since 01 mai 2022 · until 12 avril 2024

Ended
Renaud Decroix

Chairman of the board of directors · since 01 août 2020 · until 31 mai 2024

Ended
Robert Andrew Michael

Director · since 29 mars 2019 · until 30 mai 2025

Ended
Jean Antoine De Los Frailes

Director · since 08 décembre 2017 · until 26 mai 2023

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates07/05/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates06/01/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates03/09/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates19/06/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates17/04/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates22/12/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates11/07/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates16/06/2023
    DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 01/04/2026
    nominationErica Silbiger — administrateur
  2. 2025
    Annual accounts 20256,4 M €↓
  3. 01/12/2025
    nominationRolfe van de Spreng — administrateur
  4. 30/05/2025
    reconductionEY Reviseurs d'Entreprises SRL — Commissaire
  5. 2024
    Annual accounts 20246,6 M €↑
  6. 31/05/2024
    reconductionRenaud Decroix — administrateur délégué et Président du Conseil d'administration
  7. 2023
    Annual accounts 20236,3 M €↑
  8. 17/10/2023
    nominationThomas Meurice — représentant permanent du cabinet de révision (commissaire)
  9. 13/06/2023
    nominationScott Reents — Chief Financial Officer (membre du comité bancaire)
  10. 13/06/2023
    nominationLindsey Bristow — Vice President of Tax (membre du comité bancaire)
  11. 13/06/2023
    nominationPatrick Johannes Albers — Manager Treasury Operations (membre du comité bancaire)
  12. 13/06/2023
    nominationJohannes Christiaan Dunnik — Manager Treasury Operations (membre du comité bancaire)
  13. 13/06/2023
    nominationRadoika Djurdjic — Managing Director de AbbVie Central Finance BVs (membre du comité bancaire)
  14. 13/06/2023
    nominationWayne Klintworth — Assistant Treasurer (membre du comité bancaire)
  15. 26/05/2023
    reconductionJean Antoine De Los Frailes — administrateur
  16. 30/05/2022
    reconductionEY Réviseurs d'Entreprises — commissaire
  17. 2018
    Annual accounts 2018-2,1 M €↓
  18. 2017
    Annual accounts 201743,2 M €↓
  19. 2016
    Annual accounts 201656,4 M €↑
  20. 2015
    Annual accounts 2015-4,5 M €
  21. 05/04/2012
    IncorporationPublic limited company